In Brief
This article was originally published in The Tan Sheet
Executive Summary
Novartis makes OTC exec change following recall and plant shutdown; Prestige Brands adopts plan to deter Genomma takeover bid; Pfizer scoops up Emergen-C maker Alacer; CSPI threatens Amway with Nutrilite suit; more news In Brief.
You may also be interested in...
Zinc, Vitamin C Don't Reduce COVID-19 Symptoms; Impact On Shortening Colds Not Questioned
Trial with 214 adults with SARS-CoV-2 showed no significant difference among the treatment groups in number of days to symptom relief. Study didn’t measure zinc/vitamin C supplementation for shortening duration of colds.
Executive Decisions Roundup
Former FTC Member Harbour Joins Herbalife; Novartis OTC Chief McNamara Moving To GSK; New Chairman At NARB; and UrgentRx’s Eisenberg earns GS recognition
Executive Decisions Roundup
Former FTC Member Harbour Joins Herbalife; Novartis OTC Chief McNamara Moving To GSK; New Chairman At NARB; and UrgentRx’s Eisenberg earns GS recognition